|
Oncology Drug Development in
Practice
(ODDP 2014)
Amsterdam, The Netherlands,
November 26-28, 2014
Drug
development in oncology occurs mainly at the interface of pharma/biotech
companies and academic research centers. Each party needs to bring specific
expertise, facilities and skills to the arena in order to be successful in
bringing new therapies to the market. This 3-day educational program
teaches knowledge and skills needed by professionals in both the corporate
and the academic environment. It is the continuation of a highly successful
program offered annually since 2004.
Registration
for the 2014 course is now open.
Reduced non-profit
fees!
Educational
program
The
educational
program will provide thorough introductions by renowned
experts into various aspects of cancer and will cover the complete
development process and several closely associated areas:
- essentials
of tumor biology *
- oncopathology
*
- essentials
of medical oncology *
- essentials
of hemato-oncology *
- essentials
of tumor immunology and immunotherapy of cancer *
- preclinical
drug development
- early-phase
clinical studies
- late-phase
clinical development
- post-registration
clinical studies
- molecular
diagnostics and biomarkers for targeted cancer therapy
- biostatical
and regulatory issues
Target
audience
The
course is intended for everyone wishing to acquire or improve his/her
skills in the development of new cancer therapeutics. The education offered
will be particularly useful for oncology drug development professionals in
the industry, the CRO environment, and academic research institutes.
The
first day of the educational program (*) serves as a condensed introduction
into the field of oncology and cancer therapy for a broader audience and
may be booked separately.
Register
now
A
maximum of 25 participants will be accepted. Applications will be accepted
in the order in which they are received. Early registration
is therefore recommended.
|